Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Clene Inc. - Common Stock
(NQ:
CLNN
)
4.400
+0.100 (+2.33%)
Streaming Delayed Price
Updated: 4:00 PM EST, Dec 20, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Clene Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
June 12, 2024
Pre-market stock movers are worth checking out as we dive into all of the biggest news sending shares higher and lower on Wednesday morning!
Via
InvestorPlace
Why Oracle Shares Are Trading Higher By 9%; Here Are 20 Stocks Moving Premarket
June 12, 2024
Via
Benzinga
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) to Present at Emerging Growth Conference
June 11, 2024
Via
Investor Brand Network
Delays in Diagnosing MS Highlight Need for More Awareness, Research
June 10, 2024
Via
Investor Brand Network
Analyst Scoreboard: 6 Ratings For Clene
May 23, 2024
Via
Benzinga
The Analyst Verdict: Clene In The Eyes Of 5 Experts
April 17, 2024
Via
Benzinga
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) to Present at Emerging Growth Conference
June 05, 2024
Via
Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Announces Updates on ACT-EAP for CNM-Au8(R) Compassionate Use
June 04, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Issues Update on NIH-Funded Program for CNM-Au8® in ALS
May 28, 2024
Via
Investor Brand Network
Exposures
Product Safety
Clene Inc. (NASDAQ: CLNN) Participates in Three Investor Conferences During May 2024, Promoting CNM-Au8(R) Neuronal Health Therapy
May 24, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Looking to Transform Healthcare for Individuals with Neurodegenerative Diseases
May 22, 2024
Via
Investor Brand Network
Study Identifies Genetic Link Between Parkinson’s, Inflammatory Bowel Disease
May 22, 2024
Via
Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Announces Key Operational Highlights as part of First Quarter 2024 Financial Results
May 21, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Announces Participation Schedule for Upcoming May Conferences
May 14, 2024
Via
Investor Brand Network
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
May 10, 2024
The biggest pre-market stock movers are ready to go as we check out all of the hottest news happening on Friday morning!
Via
InvestorPlace
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Releases Q1 2024 Financial Numbers, Operation Highlights
May 08, 2024
Via
Investor Brand Network
Exposures
Product Safety
CLNN Stock Earnings: Clene Misses EPS, Misses Revenue for Q1 2024
May 08, 2024
CLNN stock results show that Clene missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.
Via
InvestorPlace
3 Speculative Penny Stocks Offering High-Upside Potential for Under a Buck
May 08, 2024
Although the concept of penny stocks under $1 is wildly speculative, these ideas could fly higher under the right circumstances.
Via
InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
May 06, 2024
Via
Benzinga
Study Suggests Metabolism Issues After Spinal-Cord Injury Result from Disturbed Neuronal Activity
May 03, 2024
Via
Investor Brand Network
BioMedNewsBreaks – Clene Inc. (NASDAQ: CLNN) Spotlighted in a Recent ‘From Lab to Launch’ Podcast Release
May 01, 2024
Via
Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Presents Findings on Phase 2 VISIONARY-MS LTE at American Academy of Neurology Annual Meeting
May 01, 2024
Via
Investor Brand Network
Clene Inc. (NASDAQ: CLNN) Continues Development of Lead Drug Candidate CNM Au8(R) for Neurodegenerative Diseases including Parkinson’s Disease
April 22, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Friday's After-Market Session
April 19, 2024
Via
Benzinga
BioMedNewsBreaks — Clene Inc. (NASDAQ: CLNN) Announces Study Results for CNM-Au8 as Multiple Sclerosis Treatment Presented at AAN Conference
April 17, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
April 17, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
April 17, 2024
It's time to dive into the biggest pre-market stock movers with all of the hottest news worth reading about on Wednesday!
Via
InvestorPlace
Why INVO Bioscience Shares Are Trading Higher By Around 73%; Here Are 20 Stocks Moving Premarket
April 17, 2024
Shares of INVO Bioscience, Inc. (NASDAQ: INVO) rose sharply in today’s pre-market trading after reporting fourth-quarter results.
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
April 16, 2024
Via
Benzinga
Study Identifies Three Distinct Subtypes of Multiple Sclerosis
April 15, 2024
Via
Investor Brand Network
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.